1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Czech Republic Pharmaceuticals and Healthcare Report Q1 2016

Czech Republic Pharmaceuticals and Healthcare Report Q1 2016

  • December 2015
  • -
  • Business Monitor International
  • -
  • 79 pages

Includes 3 FREE quarterly updates

BMI View: The Czech Republic's pharmaceutical market will continue to stand as one of the moreattractive to drugmakers in the Central and Eastern Europe region in the coming years Strong economicexpansion and healthcare sector growth fundamentals, including high underlying demand for healthcareand rising expenditure per capita, will underpin market expansion Meanwhile, the broader Europeaneconomic recovery will continue to act as a tailwind to high fixed investment rates in the export-intensiveCzech Republic's economy, which will benefit pharmaceutical producers

Headline Expenditure Projections

- Pharmaceuticals: CZK7677bn (USD343bn) in 2014 to CZK7883bn (USD358bn) in 2015; +27% inlocal currency terms and +46% in US dollar terms Forecasts in line with last quarter

- Healthcare: CZK28080bn (USD1254bn) in 2014 to CZK28472bn (USD1294bn) in 2015; +14% inlocal currency terms and +32% in US dollar terms Forecasts in line with last quarter

Table Of Contents

Czech Republic Pharmaceuticals and Healthcare Report Q1 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Czech Republic 2013-2019) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Czech Republic 2011-2019) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Czech Republic 2011-2019) 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Czech Republic 2011-2019) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Czech Republic 2011-2019) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Czech Republic 2011-2019) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Czech Republic 2011-2019) 23
Generic Drug Market Forecast 24
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Czech Republic 2011-2019) 25
OTC Medicine Market Forecast 26
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Czech Republic 2011-2019) 28
Pharmaceutical Trade Forecast 29
Table: Pharmaceutical Trade Data And Forecasts (Czech Republic 2013-2019) 31
Table: Pharmaceutical Trade Data And Forecasts local currency (Czech Republic 2013-2019) 31
Industry Risk Reward Ratings 32
Central And Eastern Europe Risk/Reward Index - Q1 2016 32
Czech Republic - Risk/Reward Index 39
Rewards 39
Risks 39
Regulatory Review 40
Regulatory Regime 40
Intellectual Property Environment 40
Pricing Regime 41
Reimbursement Regime 42
Table: European VAT Rates On Medicines (%) 45
Market Overview 48
Healthcare Sector 48
Table: Healthcare Resources (Czech Republic 2009-2014) 50
Table: Healthcare Personnel (Czech Republic 2009-2014) 50
Table: Healthcare Activity (Czech Republic 2009-2014) 51
Research and Development 54
Clinical Trials 55
Epidemiology 56
Competitive Landscape 59
Pharmaceutical Sector 59
Foreign Industry 60
Table: Table: Multinational Market Activity 61
Pharmaceutical Distribution 62
Pharmaceutical Retail Sector 62
Table: Retail Pharmacy Market Overview, 2006-2012 62
Company Profile 64
Zentiva (Sanofi) 64
Demographic Data 68
Demographic Forecast 68
Table: Population Headline Indicators (Czech Republic 1990-2025) 69
Table: Key Population Ratios (Czech Republic 1990-2025) 69
Table: Urban/Rural Population and Life Expectancy (Czech Republic 1990-2025) 70
Table: Population By Age Group (Czech Republic 1990-2025) 70
Table: Population By Age Group % (Czech Republic 1990-2025) 71
Glossary 73
Methodology 75
Pharmaceutical Expenditure Forecast Model 75
Healthcare Expenditure Forecast Model 75
Notes On Methodology 76
Risk/Reward Index Methodology 77
Index Overview 78
Table: Pharmaceutical Risk/Reward Index Indicators 78
Indicator Weightings 79

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.